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Disseminated encephalomyelitis has now been produced in several animal 
species by injection of emulsions of normal brain or spinal cord tissue with 
certain adjuvants (paraffin oil, aquaphor,  and killed tubercle bacilli)  (1-12). 
Attempts to produce  the  disease with emulsions of other tissues have been 
uniformly negative,  indicating  the  etiological  specificity of  nervous  tissue. 
The mechanism by which the disease is produced is still obscure. However, the 
regularity with which the condition occurs when Freund's adjuvant technic 
is used, in contrast to the difficulties in its production before adjuvants were 
employed (13-15), has been assumed to imply the operation of some immuno- 
logical process. Adjuvants have been shown to enhance antibody production 
to a  variety of antigens (cf.  reference 16) and indeed complement-fixing anti- 
bodies to alcoholic extracts of brain tissue were obtained in the monkey by 
this procedure (17).  The production of complement-fixing antibodies to brain 
and to numerous other tissues and organs has long been known (18-23;  for 
a  review cf.  24)  although most of these antibodies have not been produced 
with adjuvants. 
Experiments  in  this  laboratory  on  the  isolation  of  the  encephalitogenic 
factor have permitted the accumulation of materials for a  serological investi- 
gation of the complement-fixing antibodies produced by the injection of the 
brain emulsion and an evaluation of their possible relationship to the disease. 
Most  of  the  tests  have  been  made  with  suspensions  of lyoph~  tissue, 
standardized by dry weight, as "antigens" in preference to the alcoholic and 
watery extracts employed by previous workers  (17,  19,  23).  The use of such 
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antigens has demonstrated a  complex pattern of antibody response. Some of 
the antibodies were organ-specific, some were not. In particular, it was found 
that a large proportion of sera from monkeys injected with brain extracts, as 
well as with whole brain tissue, contained antibodies which reacted strongly, 
in  complement  fixation  tests,  with  placental  tissue.  Quantitatively,  these 
reactions with placenta much exceeded those obtained with corpus luteum, 
kidney, and testis (cf.  also reference 17). While these studies have indeed con- 
finned the existence of antibodies specific for nervous tissue, the use of placenta 
has  shown  that  certain  "antibodies  to  brain"  may be  antibodies  to  some 
element of the brain other than specifically nervous tissue, possibly vascular 
endothelium. Caution is therefore needed in interpreting results obtained with 
crude brain tissue or tissue extracts as due to antibodies specific  for brain 
tissue. For instance, sera were examined from three persons, who had received 
prophylactic antirabic treatment and were reported to us (25) as having elabo- 
rated anti-brain antibodies. With the technics employed, reactions with pla- 
cental antigen only were observed with two of the sera while the third serum 
reacted with both brain  tissue  and placenta--the  latter  reaction being  the 
stronger. Other recent reports (26) on brain antibodies in human beings after 
antirabic vaccination might,  therefore,  require  reevaluation.  No  correlation 
between the serum titer of the various complement-fixing antibodies and the 
development of encephalomyelitis in the monkey was obtained; a similar lack 
of correlation between complement-fixing antibodies to brain tissue and en- 
cephalomyelitis has been reported in dogs (27) and in mice (28). 
EXPEP~IMENTAL 
Sera.--Sera were  studied  from 82 normal control monkeys and from 89 monkeys  that 
received three weekly intramuscular injections of sterile emulsions of brain or brain extracta 
with adjuvants which had been found by assay in monkeys to have encephalitogenie power. 
Thirty-two sera were available from monkeys injected with emulsions, which in this labo- 
ratory have proven non-encephalitogenic, such as peripheral nerve, testis,  and lung,  with 
chemically treated brain emulsions with adjuvants, or with brain emulsions without tubercle 
hadlli, and with suspensions of lymphoid tissue or with monkey and rabbit sera, and served 
as controls for the complement fixation reaction. The experimental and pathological data 
for most of these have already been reported elsewhere (2-5)  and in the case of monkeys 
from more recent series the same standard~l experimental regime has been followed. When 
brain fractions (with the usual adjuvants) have been used for encephalltogenic assay their 
general nature has been indicated in the tables. More detailed chemical data may be pre- 
sented later. 
All sera contained 0.01  per cent merthiolate; they were handled with aseptic technic and 
stored at 2 ° to 4°C. The days of bleeding and of onset of signs of encephalomyelitis are re- 
corded as from the 1st day of the first injection course. For each day's tests, requisite portions 
were removed aseptically from stock and inactivated for 30 minutes at 56°C.  Preliminary 
studies confirmed the importance of this precaution and showed that inactivation will reduce 
appreciably anticomplementary properties of  older  sera,  Sera which had  become strongly 
anticomplementary were rejected; these were usually sera which had been standing for some. 
time. In the 121 experimental and 82 normal monkey sera studied the greatest anticomple- 
mentary activity has been minimal fixation at 1 : 10 dilution. At most 20 sera of the 203 used: C. ]g. LUMSDEN~  E. A. EABAT~  A. WOLF~ AND  A. E. BEZER  255 
have shown this degree of anticomplementary activity while the majority of  the monkey 
sera,  especially the more recent, have shown none at all.  Especial care has been taken in 
every set-up to have the serum controls for anticomplementary activity in the full range of 
dilutions used for the actual test. 
Cerebrospinal fluids from 22 monkeys were also examined; 6  of these came from the 89 
monkeys already referred  to while the remainder were from animals whose sera were not 
available. Human sera from 45 cases of multiple sclerosis, from 6 cases of other demyelinating 
diseases, and  from 3  patients following antirabic vaccination were investigated.  For these 
last mentioned specimens we are indebted to Dr. H.  Koprowski, New York, and for all the 
other specimens to Dr. T. J. C. yon Storch and Dr. Tiffany Lawyer of Montefiore Hospital 
and to Dr. L. V. Chiavacci of the Neurological Institute, New York. 
Antigens.--These  were  all  prepared  from  lyophilized  tissue.  The  following were  used: 
Brain from adult monkey, human being, steer,  adult rabbit, 3  day old  rabbit. With fetal 
rabbit brain two separate batches had to be used; the first consisted of the brains from a litter 
of six 18 day, the second from a  litter of 9 approximately 20 to 23 day fetuses. Other normal 
monkey organs and tissues were: Heart, lung, liver, kidney, spleen, adrenal, testis and skeletal 
muscle, and peripheral nerves. Except for the last named,  these were removed aseptically, 
cut up, stripped of any obvious fibrous stroma and large vessels, homogenized in a  blendor, 
and lyophilized. Monkey peripheral nerves (lumbar and brachial plexuses, sciatic and brachial 
nerves) were cut into short segments with scissors, pulped in a mortar, lyophilized, and then 
ground further. Even then the final material, suspended in saline, assumed a  stringy, gelati- 
nous character and gross particles were removed after milling with a  glass rod against the 
side of the container. For this reason, peripheral nerve suspension was used, arbitrarily, at 
twice the concentration of the other antigens; i.e., at 4 rag. per ml. With monkey skin it was 
found expedient to cut portions--approximately 15 ram. long by 3 or 4 mm. broad--edgewise 
on the freezing microtome; a  mass of 15 micron sections was run off on to the blade of the 
knife,  transferred  to  a  dry bottle,  and  smeared  round  the wails,  before lyophilizing. The 
lyophilized material was then ground further and yielded a  light homogeneous, flaky powder 
which suspended well in saline. "Corpus luteum" and placenta were taken from two pregnant 
rabbits. The former was prepared by first cutting the ovaries on the microtome as for the skin. 
Sample sections from each were seen microscopically to consist largely of luteal tissue. The 
pooled  placentas were drained as far as possible of blood,  homogenized in a  blendor, and 
lyophilized. Steer pituitaries were separated into anterior and posterior lobes and lyophilized 
as above. Except for the instance quoted of fetal brain, the same lyophilized powders were 
used uniformly throughout all the tests. 
Compl~ment Fixation Technic.--The  analytical technics employed  for  quantitative and 
kinetic studies on immune hemolysis (29, 30) have been used throughout. The diluent was a 
barbiturate-buffered NaCI solution with the addition of 1.0 gin. of MgCI~.6 H20 and 0.2 gin. 
of CaC12.2H20 to the 2 liter stock solution. This stock concentrate, sterilized by autoclaving, 
was diluted 1:5 with distilled water for each day's use to make an isotonic solution of pH 
7.3 to 7.4.  Sheep cells,  collected aseptically and preserved in Alsever's solution for periods 
up to a  month, were washed 5 times with buffered saline immediately before use, packed by 
centrifugation, and a  5 per cent suspension was made in buffered saline. To standardize, 1.0 
ml. of the carefully mixed suspension was lysed by the addition of 14.0 ml. of distilled water 
and the resulting Hb solution was read on the Beckman spectrophotometer at 5400/~. This 
w~ve length was adopted as optimal for this purpose on the basis of preliminary assays on 
lysed  cell suspensions primarily standardized by repeated  hemocytometric counts.  At  this 
wave length, suspensions of one million erythrocytes per mm.  t were found to yield, on lysls, 
a hemoglobin solution with an average optical density of 0.715 in the regular 10 ram. cuvette. 
The standard cell suspensions for each day's use, after preliminary reading on the Beckman, 
were adjusted accordingly. 
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titer of 1:1600.  For the titration of complement, and for use in the tests, four 100 per cent 
hemolytic units were used. Pooled  guinea pig serum, distributed in 2 to 3 ml. amounts and 
kept frozen on solid CO2, was the source of complement. An initial dilution of 1 : 25 was pre- 
pared in a  volumetric flask  from the freshly thawed  complement stock and from this an 
arithmetic series of dilutions was made in buffered  saline, separate pipettes being used for 
each dilution and all reagents being kept in ice water until the time of final incubation. For 
the titration, 1 mi. of C' dilution, 3 mi. of buffered  saline (4 ml. for the control tube), and 1 
ml. of sensitized cells were  measured into acid-washed  50 mh centrifuge tubes. These were 
capped and then incubated in the water bath at 37°C. for 45 minutes with frequent shaking. 
Then 2.5 ml. of buffered  saline was added to" each tube, the contents well mixed, and trans- 
ferred to 15 ml. tubes for centrifugation. The decanted supernatants were then read in the 
Beckman spectrophotometer at 5400 A and the lysis curve plotted accordingly. The 50 per 
cent lyric unit determined from the curve was the basic unit of measurement of C' through- 
out this work. Earlier, numerous assays were made with 5 such units but as occasional spurious 
results occurred  with partially anticomplementary sera,  6 units were finally adopted as the 
standard dosage. All results in this paper were obtained with this dosage. 
Reading and I~tterpretation of Resu/ts.--Sera were set up in the standard dilutions of 1:2, 
1:5, 1:10, 1:20, 1:40, and 1:80, sometimes being run up further to 1:320 or more. Serum 
controls have been discussed.  Appropriate antigen controls were likewise set up. Two-tenths 
ml. each of serum, complement dilution, and antigen was used in a total volume of 0.8 ml. 
and 0.2 ml. sensitized  sheep  erythrocytes added after 45 minutes' incubation at 37°C.  The 
degree  of lysis was recorded  after an additional 30 minutes at 37°C.  as follows:  Complete 
fixation of  complement--O; trace  of lysis--tr; slight lysis---sl; moderate lysis--m; strong 
lysis--str; almost complete lysis--ac; and  complete lysis  (i.e no fixation of  complement) 
--c. This method has been used in Table I; but in subsequent tables, results have been con- 
densed as follows:  -  means no fixation of C' beyond the limit (if any) of natural anticom- 
plementary effect; -4- means fixation of C' to the next dilution beyond the limit of anticom- 
plementary effect; -4- means fixation of C' to two dilutions; -4--}-, fixation of C' to three and 
four dilutions; A-+A-, fixation of C' to five dilutions and more beyond the limits of anti- 
complementary effect. By adoption of this scheme, it will be seen that pins signs have some 
quantitative significance, that a single "4- is a genuine positive representing as it does a degree 
of C' fixation beyond the doubtful zone, while the adoption of the -4- sign prevents the arbi- 
trary rejection of a possibly significant borderline result. 
RESULTS 
Table I  summarizes complement fixation results with 10 representative sera 
from  monkeys  injected with  various brain emulsions. All these  animals de- 
veloped clinical and pathological evidence of encephalomyelitis. The diversity 
of antibody patterns in the various sera is evident. Four of the sera (Nos.  7-4, 
1-65,  5-55,  2-21)  reacted  best  with  monkey  brain  and  posterior  pituitary. 
This antibody appears  to be organ-specific since it occurred in animals which 
had received rabbit, steer, or human brain. Three of these 4  reacted also with 
rabbit placenta,  1 (No.  7-4) almost as strongly as with brain, the other 2  (No. 
1-65, 5-55) to a  lesser extent; the fourth serum (No.  2-21) reacted as strongly 
with peripheral  nerve as  with  brain and pituitary.  Five of  the  remaining 6 
sera fixed complement best with monkey brain, the material which had been 
injected, and failed to  react  or reacted  but  slightly with posterior  pituitary C. E. LUMSDEN, E. A. KABAT, A. WOLF, AND A. E. BEZER  257 
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TABLE  II 
Reactions of Sera from Monkeys Injected wilh Brain Tissue from S~¢raJ Species in 
Complement Fixation Tests with Lyophilized Brain and Placental Suspensions 
Histo-  Suspension used as antigen in 
Brain  material injected  Clinical  complement fixation 
Mort-,  glgn~ Of  logic  [ 
key  enceph-  signs ot ~ 
alomy-  enceph-  Brain  Fetal  Rabbit 
No.  Source  Nature  elitis  slomY-elitis  ~onkeYbrain brainSteer  !fromday  old3  rabbit  pla- 
rabbit  brain  cents 
~-69  Monkey  Fresh  ++'b  "b  ++  "b+  +'b 
-18  "  Lyophilized  "b-I-  "b  I-b+  +4"  --  -- 
7-07  "  Benzene-extracted  resi-  .b.b  .b  I++.b  +.b.b  "4-  4-  -- 
due, calcium acetate- 
extracted 
.~-81  "  Fresh (1/27)  +++  +  +  .... 
1-62  ....  (1/18)  "b+  +  +  --  -- 
1-69  "  Lyophilized  ++  +  i+++  ++  --  -- 
~-24  "  Formalinized  ++.b  .b  +  .b+  ++.b  .b.b.b 
L77  "  Fresh (1/9)  +++  .b  .b.b  4-  --  -- 
t-03  "  Sediment  from  saline-  .b.b  .b  --  "b  4-  4- 
extracted brain (1/6) 
[-46  Rabbit  Cerebrum  from  6  day  -- 
old animal 
[-50  "  Spinal cord from 6  day +++ 
old animal 
[-65  "  Cerebrum  from  2  too.  +'b+ 
old animal  I 
[-83  "  Spinal cord from 3  day!++.b 
old animal  ! 
1-85  "  "  "  ++ 
1-86i  "  Cerebrum  from  3  day  -- 
old animal 
t-87  "  "  "  -- 
1-89[  "  "  "  -- 
71  "  Fresh 
i 
5-55  Steer  Lyophilized  .b+ 
2-21  Human  Fresh  I ++ 
-  ++  ++  ++++++  ++ 
+  +++++++++++++++ 
+  [+++  ++++++  ++ 
+  ++  ++  ++++++ 
+  +++  ++  ++  + 
_  _  ++  ++++++ 
-  -  .b.b  .b  - 
-  ±  .b.b  ++.b  - 
_  _  _  +++  - 
+  .b.b.b.b+.b+.b+.b++  .b.b 
+  +.b.b.b.b.b+++.b.b.b  - 
In Tables H  to VII; fclinical  signs are recorded as follows: -b-b-b means severe symptoms 
of encephalomyelitis; -b-b moderate and  -t- slight. Histological features of encephalomyelitis 
are recorded as present (-b), or absent  (--). The fraction signs in parentheses after "material 
injected" indicate the dilutions of brain used. 
and with monkey  peripheral nerve;  1  of these, however,  showed as strong an 
effect with rabbit placenta as with brain. The tenth animal (No. 2-24) although 
injected with monkey brain produced significant amounts of complement-fixing 
antibody  only to  rabbit placenta. C.  E.  LUMSDEN  ~ E.  A.  KABAT~ A.  WOLF~  AND  A.  E.  BEZER  259 
Table II provides further data on the organ specificity of the antibodies for 
"brain tissue in many of the sera. Nine sera from monkeys injected with monkey 
brain are given; all these animals developed encephalomyelitis.  Of the first 5 
which failed to  react with rabbit placenta,  the 3  which  reacted best  with 
monkey brain fixed equally well with steer brain and 1 of these reacted with 
rabbit brain. The single animal injected with steer brain reacted better with 
the brains of all 3 species than with placenta; monkey 2-21 injected with hu- 
man brain fixed complement strongly with monkey, steer,  and rabbit brain, 
but not with placenta. Other patterns of antibody response are also apparent. 
Two sera from monkeys injected with rabbit brain produced antibodies to 3 
day old and fetal rabbit brain but none to rabbit placenta or monkey brain; 
1 animal reacted with fetal brain only. 
Table III summarizes  the complement fixation tests on a  variety of sera 
from monkeys which had received emulsions of various tissues, some of which, 
as established  by assay in monkeys, had encephalitogenic potency while others 
<lid not. The range of reactivity with the various organs is shown. Individual 
reaction patterns are readily discernible;  some sera show no antibody, others 
only antibody to monkey brain or to rabbit placenta. Some sera show broader 
reactivity, reacting with two or three or four of the organ suspensions. These 
,organs  comprise  a  sharply restricted group  including only brain,  placenta, 
corpus luteum, and kidney with the first two giving the strongest reactions, 
~:orpus luteum was intermediate and kidney gave the weakest reactions.  No 
evidence of the reactivity with testis reported by other investigators (31, 17) 
was found. Following immunization with non-encephalitogenic materials, anti- 
l)odies only to placenta and to corpus luteum were found. 
Eighty-two control sera  from normal healthy untreated monkeys, 28  of 
~vhich were  subsequently injected and developed  encephalomyelitis  or com- 
plement-fixing antibodies or both, were  tested with monkey brain. Most of 
them were tested against fetal rabbit brain and placenta and representative 
groups were tested against the other antigens. Results were uniformly negative 
except for 1 apparently healthy female in which a sample of blood serum taken 
160 days after delivery of a healthy offspring reacted with rabbit placenta to 
a  titer of 1:80;  this result was verified on the same portion of serum on three 
separate occasions. 
Additional data on 81  monkeys are summarized  in Tables IV to VII, in- 
~:luding 59 of the 89 monkeys injected with encephalitogenic material and 22 
of the 32 animals injected with non-encephalitogenlc  material. The results are 
arranged to show the various patterns of complement fixation with different 
organ suspensions.  The day of onset of signs and the day the blood  sample 
was obtained are also given. Table IV shows 20 sera which fixed complement 
• with monkey brain but not with rabbit placenta; a  few  of these sera also 
eeacted with monkey peripheral nerve and with fetal rabbit brain.  Table V 260  ACUTE  DISSEMINATED  ENCEPHALOMYELITIS.  V 
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gives the complement fixation results with 10 sera from animals injected with 
encephalitogenic  material and with 9  sera  from monkeys injected with non- 
encephalitogenic  emulsions.  All these sera fixed complement with rabbit pla- 
centa  but  not  with  monkey brain  or,  except  for  1  animal,  with  monkey 
peripheral nerve; reactions with fetal rabbit brain were usually similar  to or 
slightly weaker  than those with rabbit placenta. Seven of the 10 animals in- 
TABLE IV 
Sera from Monkeys  ~Iz  Disseminated  Encephalomyelitis  Fixing Complemenl  with Suspen- 
sions  of Monkey  Brain  but Not Rabbit  Placenta 
Moil- 
key 
No. 
4-69 
2-02 
2-50 
2-6g 
2-77 
1-98 
2-66 
2-81 
4-62 
5-28 
5-84 
5-60 
5-61 
5-32 
5-62 
5-83 
5 -07 
5-88 
5-87 
2-21 
His- 
to  log-  Complement  fixation with 
Clinical  lc  Day 
signs  Day  of  signs  of  of  of  on-  I 
Material injected  enceph-  blood  [  Perlph-  Pla- 
en-  set  of  sam-  Fetal  eral 
MbOr  ankne  centa  alomy-  ceph-  signs  ple  • y: rabbit  nerve 
elitis  alo-  brain  (mon-  (rab- 
my-  I  key)  bit) 
elitis 
Emulsions  with enceplmlitogenic potency [  i  ! 
Monkey brain  ++  +  34  233  +++  --  --  -- 
....  (1/9)  ++  +  36  43  +++  --  +++  !  -- 
....  (1/2)  +++  +  26  28  ++  --  --  -- 
....  ++  +  51  60  ++  -  -  - 
....  (1/9)  +++  +  25  26  ++  --  I  _ 
....  (1/3)  +++  +  26  30  +  -  -  - 
....  +++  +  23  26  +;4-  --  --  -- 
....  (1/27)  -{-+-~  +  26  29  4-  --  --  -- 
....  (1/18)  ++  +  60  259  +  --  -- 
Monkey brain, benzene-extracted  resi-  ++  +  29  76  +++  -  -  - 
due  (1/9) 
....  (1/3)  +-{-  +  25  25  +-{-+  -4-  +  4- 
....  (1/3)  ++  +  19  19  +++  --  i  -4-  -- 
....  (1/3)  +++  +  15  16  +++  --  --  -- 
....  ++  +  52  52  ++  -  [  -  - 
....  (1/3)  +++  +  20  20  ++  -  -  - 
....  (1/3)  ++  +  24  24  ++  +  --  -- 
Monkey  brain, benzene-extracted  reel-  ++  +  103  103  +++  4-  I  4-  - 
due calcium acetate-extracted 
....  (1/3)  ++  +  23  23  ++4-  --  ++  -- 
....  (1/3)  +++  +  22  22  +  --  --  -- 
Human  brain  ++  +  24  32  +++  +++  +++  -- 
jected with encephalitogenic brain material failed to react in the complement 
fixation test with monkey brain although they had received  emulsions  con- 
taining monkey brain.  Table  VI  summarizes  data  on  monkey sera  which 
showed complement fixation with both monkey brain and rabbit placenta; the 
sera  are divided into three groups;  (1)  those giving  stronger reactions with 
brain than with placenta; (2) those with reactions of comparable  intensity to 
both; (3)  those with stronger reactions to placenta than to brain. Table VII 
presents 3  sera  which reacted neither with monkey brain nor with placenta C.  E.  LUMSDEN~  E.  A.  KABA%  A.  WOLF,  AND  A.  E.  BEZER  263 
but which showed complement fixation with fetal rabbit brain or with monkey 
peripheral nerve; data on 22 sere which showed no complement fixation with 
any of the 4 antigens are also included;  11 of these animals received encepha- 
litogenic emulsions. Data on the remaining sera have not been included since 
they showed essentially the same patterns as those in Tables IV to VII. None 
TABLE V 
Sera from Monkeys Fixing Complement  with Rabbit Placenta but Not with Monkey Brain 
Mon- 
key 
No. 
5-69 
4-03 
2-88 
2-98 
3-71 
7-8 
1-66 
1-3 
4-88 
4-87 
1-7 
1-6 
4-1 
1-86 
1-48 
1-47 
Material injected 
Eraulsions  witk  encepkalitogenic  #otenc~ 
Monkey brain 
....  A  (1/6) 
Own brain 
Monkey brain B  (1/2) 
Cerebrum from 13 day old rabbit 
"  "  3 month "  " 
"  "  adult  rabbit  (1  injec- 
tion only) 
F~mulslons  which  skowed no  encepkallto- 
&onlc potency 
Monkey brain C 
Rabbit brain, fetal 
Cerebrum from 3 day old rabbit 
"  "  6 day  "  " 
"  "  6 day  "  " 
Rabbit lung 
nical 
;my- 
itis 
F+ 
++ 
++ 
F+ 
lit 
Io~ 
ic 
og~  Dsy 
of on- 
en  set  of 
.~  I  sign 
g  t 
+  3: 
+  2: 
+  2~ 
+  29 
+  2: 
)ay 
of 
ood 
tm- 
)le 
46 
140  -- 
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Monkey brain A, sediment from saline-extracted brain centrifuged at 19,000 ~.P.M. 
Monkey brain B, desoxycholate extract of "A." 
Monkey brain C, whole monkey brain but with streptococcus  toxin  instead of killed tubercle bacilli, as ad- 
juvant; none of these animals developed encephalomyelitis. 
of the sera reacted with suspensions of lyophilized monkey heart,  lung,  liver, 
spleen,  muscle,  or skin;  45  sera  tested  with  lyophilized monkey testis  were 
also negative. Eight of 48 sera tested with monkey corpus luteum reacted, the 
highest titer being 1:10; all of these 8 reacted with rabbit placenta, but there 
appeared to be no quantitative parallelism in the reactions to the two antigens. 
Some sera which  reacted  with  placenta  failed  to  react with  corpus luteum. 264  ACUTE  DISSEMINATED  ENCEPHALOMYELITIS.  V 
Nine  of  57  sera  tested  reacted  in low  titer  with  monkey kidney;  3  of  these 
showed no reaction with placenta. 
Monkey Cerebrospinal Fluids.--The 22 fluids examined were all taken from 
monkeys  injected  with  monkey  brain  tissue  and  were  tested  undiluted and 
diluted 1:3 and 1: 9. In no instance were there any reactions with monkey brain. 
With rabbit placenta, however, 4 of 17 fluids fixed complement when undiluted 
TABLE VI 
Sera from Monkeys Which Fixed Complement with Monkey Brain and Rabbit Placenta 
Mon- 
key 
No. 
1-85 
1-65 
2-06 
5-70 
5-55 
5-71 
5-59 
l~Lzterial injected 
Brain  >  p~acenta 
Spinal cord from 3 day old rabbit 
Cerebrum  from 2 month old rabbit 
Monkey brain (1/27) 
Steer  " 
Monkey  " 
"  "  benzene-extracted  resi- 
due 
Intermediate 
1-50  Spinal  cord from 6 day old rabbit 
7-4  Cerebrum  from I month old rabbit 
1-46  "  "  6 day old rabbit* 
5-17 
1-83 
4-82 
2-24 
4-83 
5-58 
5-73 
ith 
Pin- 
cents. 
(rab- 
bit) 
+ 
++ 
+ 
+ 
++4. 
++a= 
+± 
+++ 
++ 
++ 
Placen~ ~  brain 
Monkey brain, benzene-extracted resi-  ++ 
due 
Spinal cord from 3 day old rabbit  +++ 
Monkey brain (1/9)  +++ 
....  (formallnized)  +++ 
....  (1/9)  +++ 
....  (1/3)  +q-q" 
....  +++ 
* Non-encephalitogenlc emulsion. 
Few mild lesions at necropsy. 
and 2  of these showed some fixation at  1:3  dilution; a  fifth undiluted fluid 
showed a  trace  of fixation. The other 12 were  completely negative.  In 3  in- 
stances  it  was  possible  to  compare  the  reactions  obtained  with  serum  and 
cerebrospinal fluid. The serum reacted with placenta to a  titer of 1:80 in all 
3  instances  while  1  cerebrospinal  fluid was  negative  and  the others reacted 
when tested undiluted and in a  1:3 dilution respectively. 
Human Sera.---Of the 3  sera  from patients treated with antirabic vaccine 
1  reacted  with  monkey brain  to a  titer  of  1:5,  and with human and  steer C.  :E.  LUMSDEN~  E.  A.  KABA%  A.  WOLF~  AND  A.  E.  BEZER  265 
brain to a  titer of 1:10. This serum, reacted, however, to a  titer of 1:80 with 
rabbit placenta. The other 2 sera reacted at  1:10 and  1:2 respectively with 
placenta but showed no reaction with brain. 
TABLE VII 
Sera from Monkeys wilh Unusual Patlcrns and with Negative Complement Fixation Tests 
Son° 
key 
No. 
7 
1-89 
2-72 
3-4 
2-0 
2-I 
2-2 
9-9 
1-24 
1-95 
2-51 
4-05 
4-58 
2-26 
3-1 
3-8 
2-9 
3-0 
1-51 
7-1 
2-19 
1-40 
2-3 
2-4 
8-7 
Material injected 
Cerebrum from adult rabbit 
"  "  3 day old rabbit* 
Monkey brain (I/3) 
Monkey peripheral nerve* 
Monkey brain 
,t  cs 
....  ('1/3) 
....  (1/2) 
Monkey  brain,  residue  after  desoxy- 
cholate extraction 
,c  ~¢ 
Monkey brain, formalinlzed 
"  "  white matter 
Rabbit  "  ,  fetal* 
Monkey peripheral nerve* 
Monkey brain, residue after ethyl alco- 
hol extraction* 
Adjuvants only intracerebrally* 
Human brain§ 
Abdominal exudste and lymphoid tis- 
sue* 
Monkey serum intravenously* 
Rabbit  "  " 
th 
Pla- 
.-enta 
(b~b-  it) 
-4- 
-4- 
m 
* Non-encephalitogenlc material. 
~t  Few mild lesions. 
§ Brain emulsion without tubercle bacilli  in right side; tubercle bacilli  emulsion without brain left  side. 
The  multiple  sclerosis  sera  came  from  45  patients  with  well  established 
cases dating back  1 to 25 years; there were sera from 6  cases of suspected 
early multiple sclerosis and from one case diagnosed as neuromyelitis optica. 
All these sera were tested with the lyophilized human brain, monkey brain, 
and rabbit placenta used in the tests on the monkey sera.  The complement 
fixation tests were completely negative throughout. 266  ACUTE DISSEMINATED ENCEPHALOMYELITIS. V 
DISCUSSION 
The data presented make abundantly clear the complexity of the antibody 
response to the injection of a heterogeneous  group of antigens such as whole 
brain. Individual monkeys produced complement-fixing antibodies to one or 
more of the constituents of brain tissue and by examination of the various pat- 
terns of these sera  a  number of types of distinct antibodies could be recog- 
nized. One of these types is organ-specific brain antibody which reacts with 
human, monkey, rabbit, and steer brain, and with the posterior  lobe of the 
pituitary but which fails to react with other tissues; this type of antibody was 
produced only by the injection of brain tissue  but the species of brain em- 
ployed was  not  of  consequence,  monkey, rabbit,  human,  and  steer  brain 
stimulating this type of antibody (Tables I, II, IV, and VI) in some instances. 
A  second  type  of  antibody was  detected primarily by its reaction with 
rabbit placenta.  This antibody also  appears  to  be  "organ-  "  rather than 
species-specific in that it was produced by the injection of monkey, rabbit, or 
steer tissues. The antigen involved does not appear to be limited exclusively 
to brain and placenta since the antibody reacting to placenta was produced 
in the 3 monkeys injected with emulsions of rabbit lung (Tables  III and V). 
This antigen appears to he responsible for most of the complement fixation 
reactions with fetal rabbit brain tissue in animals which showed no complement 
fixation with adult monkey brain  (Table  V)  since the reactions to the two 
antigens are generally similar.  With both the fetal brain suspension and the 
antisera  to  rabbit  lung,  the  possibility  of  some  species-specific antigen  in 
addition to the placental antigen cannot be ruled out except by further study. 
It is not known to which constituent of monkey brain or rabbit placenta this 
reaction is attributable but it is possible that it may be vascular endothelium 
since both of these tissues are so highly vascular.  The reactions with fetal brain 
would be consistent  with this interpretation. Were this the case, however,  it 
might be expected  that other highly vascular tissues  should  also react. Re- 
actions with kidney, however,  were  infrequent and relatively weak.  This is 
not unexpected,  since the antigens employed in the tests were prepared from 
whole lyophilized  organs  and the proportions of vascular tissue  might vary 
from one to the other. Further studies using better sources of vascular endo- 
thelinm such as the isolated glomeruli of Solomon et al.  (32) might lead to a 
more definite  identification  of the antigen in brain and placenta responsible 
for this reaction. 
Antibodies to other constituents of the brain tissue may also be formed but 
these are  less  common.  Individual  sera  reacting  strongly  only  with  fetal 
rabbit brain  (Table  VII, Nos.  7 and 1-89) or only with monkey brain and 
peripheral  nerve  (Table  IV,  Nos.  2-02, and  5-88), or  predominantly with 
brain and posterior pituitary (Table I, Nos. 1-55, and 5-55) or with brain but 
slightly or not at all with posterior pituitary (Table I, Nos. 5-07, 5-84, and 5-88) C.  E.  LUMSDEN,  E.  A.  KABA%  A.  WOLF,  AND  A.  E.  BEZER  267 
serve as examples. Another type is represented by those sera which react with 
corpus luteum  (Table  III).  The nature and significance of these antibodies 
are as yet unknown. 
The complex nature of the antibody response to the injection of brain tissue 
should emphasize  the  difficulty of attributing any complement fixation re- 
action in serum to nervous tissue. The three sere from human beings given 
rabies vaccine (25)  apparently produced antibodies to an antigen other than 
those of the neural elements of brain tissue. The extent to which antibody 
formation to antigens other than those specific  for nervous tissue was a  com- 
plicating factor in the studies on the relationship of complement-fixing anti- 
bodies to encephalomyelitis in dogs (27) and in mice (28) cannot be evaluated 
except by extensive serological studies.  Since these latter animals were  sub- 
jected essentially to the same immunizing procedure, it is probable that they 
+oo developed a multiplicity of antibodies. 
The relation of the various complement-fixing antibodies to  the encepha- 
lomyelitis is very difficult to determine. The antibody fixing complement with 
placenta can readily be excluded since it has been produced with non-encepha- 
litogenic emulsions such as fetal rabbit'brain and lung  (Tables  IV to VII). 
With respect to the complement-fixing antibodies to brain, the 89 sera from 
monkeys injected with encephalitogenic emulsions fell into 4 groups distributed 
as follows:-- 
Disseminated encephalomyelitis 
-b 
Total .............................. 
q- 
48 
5 
53 
Complement fixation 
21 
15 
36 
Totals 
69 
20 
89 
From these data, it would appear  that statistically there is a  high degree 
of correlation between  the  appearance  of  complement-fixing antibodies  to 
brain and the occurrence of disseminated encephalomyelitis. This, however, 
may merely be a  consequence of the animals having responded generally in 
parallel to more than one of the antigens in the brain emulsion and does not 
necessarily in any way imply any etiological relationship between the com- 
plement-fixing antibodies and the encephalomyelitis. Indeed the existence of 
two  groups,  one  showing  complement-fixing antibodies  but  no  clinical  or 
histological  evidence  of  encephalomyelitis  (5  animals)  and  another  larger 
group  (21  animals)  showing  no  complement-fixing antibodies  but  definite 
clinical and histological evidence of encephalomyelitis, weighs in the direction 
of no etiological relationship between the two phenomena.  The first of these 
two groups, those with no encephalomyelitis but with complement-fixing anti- 268  ACUTE  DISSEMII~ATED  ENCEPHALOMYELITIS.  V 
bodies, does not contribute as convincingly to the evidence against an etio- 
logical relationship as it might, since of the 5 animals involved only 1 showed 
stronger complement fixation to brain than to placenta,  1 showed reactions 
of equal intensity to both, and the remaining 3 reacted more strongly to pla- 
centa than to brain. The possibility that 3 or 4 of these 5 might therefore have 
only antibody to the placental antigen and not to brain, cannot be excluded; 
were this the case 4  of these animals would fall into the group negative for 
both encephalomyelitis and complement fixation to monkey brain. 
With respect to the animals showing encephalomyelitis an attempt to cor- 
relate the complement-fixing antibodies with the severity of the clinical dis- 
ease gave the following results: 
Severity of disease 
-b 
-b-b 
-b-b+ 
0 
8 
13 
Complement fixation reaction 
+  ++ 
3  3 
3  2 
9  7 
9  6 
+++ 
* No symptoms  observed in this animal; few lesions histologically. 
The dam clearly show the absence of correlation between the degree of com- 
plement fixation and  the  severity of the  encephalomyelitis; of especial  sig- 
nificance is the finding that all but one of the 22 animals that showed no com- 
plement-fixing antibodies showed moderate or severe disease. 
The data were scrutinized with respect to the comparability of the times at 
which the serum rumples for complement fixation were taken in relation to 
the appearance of clinical symptoms. The median day for the appearance of 
symptoms in 197 monkeys with encephalomyelitis studied in this laboratory 
during the past 5 years was 30 with the first and third quartiles falling on days 
25 and 44 with symptoms occasionally occurring up to 164 days. For the 68 
animals with encephalomyelitis in this study the median day was 29 and the 
first and third  quartiles  on the  24th  and 40th  day respectively, symptoms 
occurring as late as 116 days; the incubation period in the experimental group 
of  animals  developing  the  disease  was,  therefore,  representative.  For  the 
complement fixation studies the median day on which the serum samples were 
taken was 42 with the first and third quartiles occurring 27 and 82 days after 
the first injection: The  bulk  of the samples were taken in the  2 weeks im- 
mediately following the day of onset of symptoms. Of the 68 animals showing 
symptoms  of  encephalomyelitis all  but  15  were  examined  in  complement 
fixation tests within I week of the onset of symptoms. The 16 animals showing 
neither encephalomyelitis nor complement-fixing antibodies were bled from 28 
to 291 days after the first injection. C.  E.  LUMSDEN,  F..  A.  KABAT,  A.  WOLF,  AND  A.  E.  BEZER  269 
It is also of interest  that  4  animals  which had  shown signs of encephalo- 
myelitis and had gone into a  remission showed complement fixation reactions 
180, 233, 239, and 259 days after the first injection of brain emulsion although 
they appeared well; at necropsy these animals showed histological evidence of 
encephalomyelitis. 
The findings are probably best summarized  by stating  that  the data show 
no  correlation  between  the  various  complement-fixing  antibodies  and  the 
encephalomyelitis and consequently provide no support for an hypothesis that 
the complement-fixing antibodies to brain which are demonstrable in the serum 
of  monkeys  injected  with  brain  emulsions  plus  adjuvants  are  etiologically 
responsible for the encephalomyelitis. 
SUMMARY 
I. Animals injected with emulsions of monkey brain with adjuvants show 
a complex pattern of antibody response as determined by complement fixation 
tests. 
2.  Organ-specific complement-fixing antibodies to constituents of brain tissue 
may  be formed which  fix complement  with  brain  tissues  of  various  animal 
species but fail to react with other organs or with rabbit placenta. 
3.  Antibodies may be formed to some constituent of brain other than nervous 
tissue.  It would seem that  these can be detected by the strong  complement 
fixation given with rabbit placenta. 
4.  Sera  from  individual  animals  may  contain  antibodies  to  the  brain  or 
placenta  constituents,  to both, or to neither.  Occasional individual  sera show 
unique  patterns  of antibody  response as determined  with  various  additional 
antigens such as fetal brain, posterior pituitary,  or peripheral  nerves. 
5.  No evidence of any etiological  relationship between the  development  of 
encephalomyelitis and the complement-fixing antibodies to brain demonstrable 
in the sera could be found. The complement-fixing antibody to the placental 
constituent was unrelated  to the encephalomyelitis. 
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